Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»A New Study Has Identified Genes Associated With the Most Aggressive Kidney Cancer
    Health

    A New Study Has Identified Genes Associated With the Most Aggressive Kidney Cancer

    By National Research University Higher School of EconomicsJanuary 6, 2023No Comments4 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Cancer Cells Dividing
    Clear cell renal carcinoma (CCRC) is a type of kidney cancer that is characterized by the presence of clear cells in the tumors. It is the most common type of kidney cancer in adults, accounting for about 70-80% of all kidney cancers. CCRC tends to grow and spread quickly, and it is often diagnosed at later stages when it has already spread to other parts of the body.

    Researchers have discovered that certain cancer cells express genes that are responsible for blood clotting, which could potentially be targeted with anticoagulants in cancer treatment.

    Researchers from the HSE have discovered genes that are specific to the most aggressive subtype of clear cell renal carcinoma. Grigory Puzanov, a research fellow at the HSE Faculty of Computer Science International Laboratory of Bioinformatics, analyzed data from 456 patients with the disease and identified cancer subtypes that either had a favorable or unfavorable prognosis. The findings were published in the journal Scientific Reports.

    Clear cell renal carcinoma (ccRCC) is the most common type of kidney cancer. In the past few decades, the number of new cases has been increasing. Although there is a significant amount of data on this disease, there is still a lack of information on specific human genes that could help predict its clinical course.

    Gene Expression Insights and Tumor Clusters

    Findings from Puzanov’s study reveal which ccRCC subtypes are more dangerous than others and which human genes appear to be responsible for the progression of the disease. This new information is significant for the early detection of aggressive tumors and for designing personalized treatment plans for ccRCC patients.

    The author analyzed data from The Cancer Genome Atlas (TCGA) on 456 tumor samples for which no radiotherapy or additional pharmacotherapy was performed. Subtypes with different survival rates were identified using the k-means method for clustering samples into subgroups with similar characteristics. For gene clustering, Puzanov selected 2,000 genes with highly variable expression patterns in ccRCC.

    Gene expression is the process by which a gene is read and copied to produce a messenger RNA (mRNA) which is then used to synthesize proteins.

    A bioinformatic algorithm was run 100 times, each time sorting the tumor samples based on the similarity of the 2,000 genes’ expression patterns. Three clusters (subtypes) with different survival rates were identified. The cluster with the lowest survival rates was associated with metastases and the worst response to subsequent treatment.

    The study was carried out in several stages. In stage one, each cluster’s characteristics were examined for a better understanding of genetic factors which could influence the course of the disease. Then, the study author identified the key genes specific to high and low survival clusters and constructed a network of interactions for proteins whose synthesis is encoded by these genes.

    Key Genes Driving Poor Prognosis

    Puzanov’s analysis determined which genes encoded proteins with the highest number of network connections. The cluster with the poorest survival rates was found to be associated with the MFI2, CP, APOB, and ENAM genes known to be involved in the transport of insulin-like growth factor (a protein similar in structure to insulin) and in post-translational modification of proteins. In addition, specific to the low-survival subtype were the genes encoding fibrinogen and prothrombin associated with blood clotting (FGA, FGG, and F2).

    “Some of these key genes may affect the efficacy of anti-tumor therapies. For example, increased activity of the CP, FGA, and FGG genes is associated with poor response to nivolumab, and high expression of APOB and ENAM predicts a lack of response to sunitinib. This knowledge can help in prescribing the most suitable targeted treatments for patients with malignancies” – Grigory Puzanov, Research Fellow, International Laboratory of Bioinformatics, Faculty of Computer Science, HSE University

    According to the researcher, the combined use of conventional anti-tumor agents and anticoagulants (medicines that help prevent blood clots) can increase the effectiveness of cancer treatment. Thus, there is evidence that heparin, which is commonly used to treat thromboembolic events in cancer patients, contributes to patient survival and has anti-metastatic activity.

    Reference: “Identification of key genes of the ccRCC subtype with poor prognosis” by Grigory Andreevich Puzanov, 26 August 2022, Scientific Reports.
    DOI: 10.1038/s41598-022-18620-y

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Cancer Genetics Kidney Tumor
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Why Do Tumors Form? Scientists Challenge Long-Held Cancer Predisposition Beliefs

    New Research Overturns Decades-Old Beliefs About How Cancer Grows and Spreads

    New Assay Could Revolutionize Acute Myeloid Leukemia Treatment

    Against the Odds: Genetic Code of Rare Kidney Cancer Cracked

    A New Treatment for a Rare and Complex Cancer

    Not Just One Type – Identifying Cancer Genes’ Multiple Personalities

    A Flip of a Genetic Switch: Stopping a Rare Childhood Cancer in Its Tracks

    Cervical Cancer Breakthrough: Major New Clue to Better Understanding the Disease

    A New Approach to Treating a Lethal Type of Cancer

    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Hidden Brain Signals Could Predict Alzheimer’s Years Before Symptoms Appear

    The Solar System May Have a 6th Dwarf Planet – and It’s Been Hiding in Plain Sight

    New Research Identifies the Hidden Rules That Help Brain Cancer Evade Treatment

    Smiling Isn’t Always Good for You, Scientists Discover

    Scientists Discover Climate Change May Have Stopped Earth’s Next Ice Age

    Quantum Discovery Reveals Why More Powerful Lasers Can Actually Slow Atoms Down

    Einstein Was Right Again: Scientists Discover Chemical Bonds That Defy Textbook Rules

    NASA Space Telescope Meets Fiery End After Nearly 22 Years in Orbit

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Brick Kilns Became Cleaner and More Profitable, but Workers Saw No Benefits
    • Antarctica’s Melting Ice Has Triggered a Sudden Shift Deep in the Ocean
    • NASA Warns a Monster El Niño Could Surpass the Historic 1997 Event
    • Researchers Discover New Lace Bug Species on Japan’s Remote Ogasawara Islands
    • How a Single Missing Atom Can Leave a Secret Fingerprint in Laser Light
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.